Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Slavin

Showing results (181-190 of 436) with videos related to

Pageof 44
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1985
The role of suppressor T lymphocytes in the maintenance of tolerance to alloantigens in bone marrow chimeras prepared with total lymphoid irradiation (TLI)S Slavin, M Weigensberg, S Bar, et al.
Bone Marrow Transplantation|March 1, 1988
Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT)E Kedar, R Or, E Naparstek, et al.
Bone Marrow Transplantation|September 1, 1990
The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?S Slavin, A Ackerstein, E Naparstek, et al.
International Journal of Cancer|March 28, 1997
Induction of graft vs. tumor effect in a murine model of mammary adenocarcinomaS Morecki, Y Moshel, Y Gelfend, et al.
International Immunology|October 1, 1996
Linomide, an immunomodulator that inhibits Th1 cytokine gene expressionG Arad, M Katzenellenbogen, R Levy, et al.
British Journal of Haematology|October 1, 1983
Serum transcobalamin levels as an early indicator of bone marrow engraftment following transplantationE Naparstek, B Rachmilewitz, M Rachmilewitz, et al.
Experimental Hematology|September 29, 2000
Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantationA Nagler, R Or, E Naparstek, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinomaS Morecki, E Yacovlev, Y Gelfand, et al.
Bone Marrow Transplantation|August 1, 1993
Optimization of conditioning therapy for leukemia prior to BMT. I. Optimal synergism between cyclophosphamide and total body irradiation for eradication of murine B cell leukemia (BCL1)E Loewenthal, L Weiss, S Samuel, et al.
Bone Marrow Transplantation|May 29, 1998
Bone marrow transplantation from a cadaveric donorJ Kapelushnik, M Aker, T Pugatsch, et al.
Pageof 44

Showing results (181-190 of 436) with videos related to

Sort By:
Pageof 44
Advances in Experimental Medicine and Biology|January 1, 1985
The role of suppressor T lymphocytes in the maintenance of tolerance to alloantigens in bone marrow chimeras prepared with total lymphoid irradiation (TLI)S Slavin, M Weigensberg, S Bar, et al.
Bone Marrow Transplantation|March 1, 1988
Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT)E Kedar, R Or, E Naparstek, et al.
Bone Marrow Transplantation|September 1, 1990
The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?S Slavin, A Ackerstein, E Naparstek, et al.
International Journal of Cancer|March 28, 1997
Induction of graft vs. tumor effect in a murine model of mammary adenocarcinomaS Morecki, Y Moshel, Y Gelfend, et al.
International Immunology|October 1, 1996
Linomide, an immunomodulator that inhibits Th1 cytokine gene expressionG Arad, M Katzenellenbogen, R Levy, et al.
British Journal of Haematology|October 1, 1983
Serum transcobalamin levels as an early indicator of bone marrow engraftment following transplantationE Naparstek, B Rachmilewitz, M Rachmilewitz, et al.
Experimental Hematology|September 29, 2000
Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantationA Nagler, R Or, E Naparstek, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinomaS Morecki, E Yacovlev, Y Gelfand, et al.
Bone Marrow Transplantation|August 1, 1993
Optimization of conditioning therapy for leukemia prior to BMT. I. Optimal synergism between cyclophosphamide and total body irradiation for eradication of murine B cell leukemia (BCL1)E Loewenthal, L Weiss, S Samuel, et al.
Bone Marrow Transplantation|May 29, 1998
Bone marrow transplantation from a cadaveric donorJ Kapelushnik, M Aker, T Pugatsch, et al.
Pageof 44